{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:26:19Z","timestamp":1791228379046,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejim.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:36:35Z","timestamp":1742387795000},"page":"108-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5517","authenticated-orcid":false,"given":"Ruggiero","family":"Mascolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1078-1632","authenticated-orcid":false,"given":"Maddalena Alessandra","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-7040","authenticated-orcid":false,"given":"Silvia","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pancrazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4130-5519","authenticated-orcid":false,"given":"Lucia","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2711-7148","authenticated-orcid":false,"given":"Elisa","family":"Ceriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-8857","authenticated-orcid":false,"given":"Lisa","family":"Serati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8939-1513","authenticated-orcid":false,"given":"Luisa","family":"Carrozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-2168","authenticated-orcid":false,"given":"Elisa","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-5354","authenticated-orcid":false,"given":"Ferruccio","family":"Ceriotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1203-000X","authenticated-orcid":false,"given":"Alessandro","family":"Andreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0008-4630","authenticated-orcid":false,"given":"Valentino","family":"Collini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5600","authenticated-orcid":false,"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.03.011_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023252","article-title":"Interleukin-1 trap rilonacept improved health-related quality of life and sleep in patients with recurrent pericarditis: results from the phase 3 clinical trial RHAPSODY","volume":"11","author":"Brucato","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.03.011_bib0002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CRD.0000000000000356","article-title":"Clinical burden and unmet need in recurrent pericarditis: a systematic literature review","volume":"30","author":"Klein","year":"2022","journal-title":"Cardiol Rev"},{"issue":"1","key":"10.1016\/j.ejim.2025.03.011_bib0003","first-page":"e11776","article-title":"Duration of disease and long-term outcomes in patients with difficult-to-treat recurrent pericarditis: a chronic condition treated with nonsteroidal anti-inflammatory drugs","volume":"7","author":"Ceriani","year":"2025","journal-title":"Colchicine, Corticosteroids, and Anti-Interleukin-1 Agents. ACR Open Rheumatol."},{"key":"10.1016\/j.ejim.2025.03.011_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2023.03.034","article-title":"Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein: a systemic autoinflammatory disease? A cohort study","volume":"113","author":"Pisacreta","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/1756-185X.14523","article-title":"Relapsing pericarditis: peripheral blood neutrophilia, lymphopenia and high neutrophil-to-lymphocyte ratio herald acute attacks, high-grade inflammation, multiserosal involvement, and predict multiple recurrences","volume":"26","author":"Tombetti","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ejim.2025.03.011_bib0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/14740338.2021.1960980","article-title":"Current treatment of recurrent pericarditis: safety considerations and future directions","volume":"21","author":"Imazio","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ejim.2025.03.011_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thuno","year":"2009","journal-title":"Dis Markers."},{"key":"10.1016\/j.ejim.2025.03.011_bib0009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2011.02363.x","article-title":"Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study","volume":"270","author":"Huttunen","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.2011.02372.x","article-title":"suPAR - a future risk marker in bacteremia","volume":"270","author":"Eugen-Olsen","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0011","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cjca.2015.03.023","article-title":"suPAR: a new biomarker for cardiovascular disease?","volume":"31","author":"Hodges","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10408363.2016.1269310","article-title":"The intriguing role of soluble urokinase receptor in inflammatory diseases","volume":"54","author":"Desmedt","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.ejim.2025.03.011_bib0013","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00424-017-2026-7","article-title":"suPAR and chronic kidney disease-a podocyte story","volume":"469","author":"Zeier","year":"2017","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejim.2025.03.011_bib0014","article-title":"Soluble urokinase plasminogen activator receptor levels and outcomes in patients with heart failure","author":"Hayek","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.ejim.2025.03.011_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000524965","article-title":"An inflammatory mediator for kidneys","volume":"8","author":"Sudhini","year":"2022","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.ejim.2025.03.011_bib0016","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14740\/jocmr4459","article-title":"Soluble urokinase plasminogen activator receptor as a diagnostic and prognostic biomarker in cardiac disease","volume":"13","author":"Velissaris","year":"2021","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.ejim.2025.03.011_bib0017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2011.01.049","article-title":"Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events","volume":"216","author":"Sehestedt","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2025.03.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.medcli.2024.04.019","article-title":"Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism","author":"Oblitas","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ejim.2025.03.011_bib0019","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1160\/th15-06-0511","article-title":"Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism","volume":"115","author":"Engstrom","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2025.03.011_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13054-020-02897-4","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia","volume":"24","author":"Rovina","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ejim.2025.03.011_bib0021","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijid.2021.04.026","article-title":"Admission levels of soluble urokinase plasminogen activator receptor (suPAR) are associated with the development of severe complications in hospitalised COVID-19 patients: a prospective cohort study","volume":"107","author":"Oulhaj","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ejim.2025.03.011_bib0022","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028456","article-title":"Interleukin (IL-6) Immunotherapy","volume":"10","author":"Tanaka","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0024","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/jir.2011.0062","article-title":"Interleukin-6 in sepsis and capillary leakage syndrome","volume":"32","author":"Kruttgen","year":"2012","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.ejim.2025.03.011_bib0025","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A - a review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0028","article-title":"Serum amyloid A in inflammatory rheumatic diseases: a compendious review of a renowned biomarker","volume":"11","author":"Soric Hosman","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0029","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41420-023-01455-5","article-title":"Serum amyloid protein A in inflammatory bowel disease: from bench to bedside","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ejim.2025.03.011_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0000000000001134","article-title":"The value of serum amyloid A levels in familial Mediterranean fever to identify occult inflammation during asymptomatic periods","volume":"27","author":"Cakan","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0031","first-page":"207","article-title":"Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report","volume":"31","author":"Cantarini","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0032","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s15010-020-01468-7","article-title":"Prognostic value of serum amyloid A in patients with COVID-19","volume":"48","author":"Cheng","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.ejim.2025.03.011_bib0033","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2025.03.011_bib0034","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCULATIONAHA.120.051156","article-title":"Incessant pericarditis as a risk factor for complicated pericarditis and hospital admission","volume":"143","author":"Imazio","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.03.011_bib0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.echo.2013.06.023","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography","volume":"26","author":"Klein","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ejim.2025.03.011_bib0036","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0037","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.110.986372","article-title":"Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis","volume":"123","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.03.011_bib0038","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11739-019-02057-9","article-title":"Acute pericarditis or a systemic disease with pleuropulmonary involvement?","volume":"14","author":"Wu","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"18","key":"10.1016\/j.ejim.2025.03.011_bib0039","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of Anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2025.03.011_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245837","article-title":"The complex role of C-reactive protein in systemic Lupus Erythematosus","volume":"10","author":"Enocsson","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2025.03.011_bib0041","first-page":"815","article-title":"Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis","volume":"20","author":"Gabay","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0042","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/art.24316","article-title":"C-reactive protein and systemic lupus erythematosus","volume":"59","author":"Gaitonde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2025.03.011_bib0043","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000319021","article-title":"Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke","volume":"30","author":"Kuhlenbaeumer","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejim.2025.03.011_bib0044","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/ddh021","article-title":"Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus","volume":"13","author":"Russell","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejim.2025.03.011_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/clinchem\/39.2.293","article-title":"Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases","volume":"39","author":"Nakayama","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2025.03.011_bib0046","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/art.38408","article-title":"Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-alpha and a C-reactive protein gene variant","volume":"66","author":"Enocsson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0047","article-title":"C-reactive protein levels in systemic Lupus Erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205","volume":"11","author":"Enocsson","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjc.2024.03.010","article-title":"INFLA-score: a new diagnostic paradigm to identify pericarditis","author":"Andreis","year":"2024","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0049","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2023.04.046","article-title":"Treatment of idiopathic recurrent pericarditis with goflikicept: phase II\/III study results","volume":"82","author":"Myachikova","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.03.011_bib0050","article-title":"Rilonacept use in lupus pericarditis","author":"Fava","year":"2024","journal-title":"Clin Exp Rheumatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T20:35:47Z","timestamp":1746218147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"alternative-id":["S0953620525000974"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.03.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}